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Abstract


ABSTRACT
Synopsis of the thesis entitled “Chemoenzymatic synthesis of biologically active entities, synthesis of both the stereoisomers of dihydrokawain-5-ol and development of novel synthetic methodologies” has been divided into four chapters.
Chapter-I: Biotransformations: Introduction and Background Information 
Chapter-II 
Section-A: A new chemoenzymatic Baylis-Hillman approach for the synthesis      	    of enantiomerically enriched umbelactones.
Section-B: Chemoenzymatic synthesis of (R)-GABOB and (R)-carnitine.
Chapter-III 
Section A: Chemoenzymatic synthesis of (-)-centrolobine.
Section B: Chemoenzymatic synthesis of (R) and (S) enantiomers of timolol.
Chapter-IV
Section-A: Chemoenzymatic synthesis of enantiomerically enriched           kawalactones.
Section-B: Enantioselective total synthesis of both the stereoisomers of
 dihydrokawain-5-ol.
Section-C: Cu(BF4)2·xH2O catalyzed one-pot synthesis of Biginelli and Strecker reactions.








Chapter-I: Biotransformations: Introduction and Background Information 
This chapter describes a concise and general account of enzymes. It also brings about a brief account of importance of chirality, classification of lipases and their applications in organic synthesis for various stereoselective transformations.
Chapter-II 
This chapter has been devided into two sections. Section-A describes a new chemoenzymatic Baylis-Hillman approach for the synthesis of enantiomerically enriched umbelactones and section-B describes chemoenzymatic synthesis of (R)-GABOB and (R)-carnitine.
Section-A: A new chemoenzymatic Baylis-Hillman approach for the synthesis of enantiomerically enriched umbelactones

(R)-Umbelactone-1 is one example of a naturally occurring -(hydroxymethyl)--butenolide which was isolated from Memycelon umbelatum Brum. The crude extracts of this plant have shown antiviral (activity against Ranikhet disease virus), antiamphetory and spasmolytic activity as a result, it has been considered that the synthesis of umbelactone is of particular interest.
The synthesis was commenced from compound 3 as a precursor, which was prepared from aldehyde 2 upon treatment with with methyl acrylate and quinuclidine applying Baylis-Hillman strategy in quantitative yields. The hydroxyl of 3 was protected as TBS ether using TBSCl and imidazole to give 4 in high yield. Unsaturated ester 4 was reduced to the alcohol 5 by DIBAL-H in CH2Cl2 in 95% yield, which subsequent tosylation with using tosyl chloride and triethly amine in CH2Cl2 (in the presence of catalytic amount of DMAP) as tosyl ether 6 in 75% yield. Further, 6 was reduced to methyl group with LiAlH4 in THF to give 7, this upon deprotection of TBS group using TBAF in THF gave the required intermediate 8.
Having successfully completed the synthesis of 8, our focus was aimed at the development of lipase-catalyzed transesterification of racemic hydroxy group to obtain enantiomerically pure (R)-9 and (S)-8, which would be useful for the synthesis of enantimerically enriched umbelactones (R)-1 and (S)-1 (Scheme 1).
Scheme 1
 Reagents and conditions: i. Methyl acrylate, quinuclidine, MeOH, 90%, 8 h; ii. TBDMSCl, imidazole, CH2Cl2, DMAP 0 °C to rt; 96%; iii. DIBAL-H, CH2Cl2, -78 °C, 95%; iv. TsCl, Et3N, CH2Cl2, DMAP, rt, 4 h, 75%; v. LiAlH4, THF, 88%; vi. TBAF, THF, 0 °C to rt, 85%; vii. Lipase, vinyl acetate, hexane; viii. K2CO3, MeOH, 90%; ix. Acryloyl chloride, Et3N, CH2Cl2, DMAP, 0 °C to rt, 30 min, 90%; x. II, CH2Cl2, 35 °C; xi. TiCl4, CH2Cl2, 0 °C to rt, 10 min, 90%.
Section-B: Chemoenzymatic synthesis of (R)-GABOB and (R)-carnitine
Amino-hydroxybutyric acid (GABOB) is a compound of great pharmacological importance because of its biological function as a neuromodulator in the mammalian central nervous system. The (R)-form of GABOB is shown to have greater biological activity than its S-enantiomer. Moreover, the (R)-isomer of GABOB serves as a precursor for (R)-carnitine, a compound having high level of medical significance. Carnitine is a vitamin like substance and plays an important role in converting stored body fat into energy. Its primary physiological function is to transport long chain fatty acids through the mitochondrial membrane into the cellular compartments for oxidation where these fats can be converted into energy. Moreover, there are several medical indications for which carnitine has been prescribed these include its usefulness as a pharmaceutical for hemodialysis (hypolipidemic agent), heart diseases etc. 
An efficient method for the preparation of (±)-N-(3-cyano-2-hydroxy propan-1-yl)phthalimide 17 and its successful enzymatic resolution have been described. This lipase-mediated transesterification process has been optimized with respect to different lipases and solvents. Furthermore, enantiomerically pure N-(3-cyano-2-hydroxy propan-1-yl)phthalimide-(R)-17b has been employed in the preparation of (R)- GABOB-(R)-12 and (R)-carnitine (R)-13.




Chapter III 
This chapter has been divided into two sections. Section A describes the chemoenzymatic synthesis of (-)-centrolobine 19 and Section B describes the Lipase-catalysed resolution of 1-chloro-3-[(4-morpholin-4-yl-1,2,5-thiadiazole-3-yl)oxy) propan-2-ol. Synthesis of (R) and (S)-timolol.
Section A: Chemoenzymatic synthesis of (-)-centrolobine


(-)-Centrolobine-19

Reagents and conditions: i. BnBr, K2CO3, acetone, reflux, 10 h, 90%; ii. (COCl)2, DMSO, -78 °C, 2 h, then NEt3,  -78 °C to –10 °C, 88%; iii. Allyl bromide, Zn, THF, 3 h, 90%; iv. Lipase, vinyl acetate, diisopropyl ether; v. (a) 4-Nitro-benzoic acid, PPh3, DEAD, 95%; (b) K2CO3, MeOH, rt, 1 h 90%; (c) Acryloyl chloride, NEt3, CH2Cl2, 1 h, 90%; vi. Grubbs’ 2nd generation catalyst, CH2Cl2, reflux, 30 h, 80%; vii. Pd/C, H2, EtOAc, 4 h, 90%; viii. (a) p-MeO-C6H4-MgBr, THF, -78 °C, 1 h, 76%; (b) BF3.Et2O, Et3SiH, CH2Cl2, -78°C then rt, 1 h, 65 %. 
(-)-Centrolobine 19 was isolated from the heartwood of Centrolobium robustum and from the stem of Brosinum potabile. Recently, (-)-centrolobine 19 and related natural products have been shown to be active against Leishmania amazonensis promastigotes; a parasite associated with leishmaniasis, a major health problem in Brazil. Leishmaniasis is a parasitic disease transmitted by the sand fly, and is related to Indian dum dum fever. Once in its human host, the parasite attacks the spungiform organs of the body, especially the liver and spleen, where the initial symptoms include a high fever, meaning that the disease is often mistaken for malaria. If the parasite attacks the skin, similar symptoms to leprosy arise, again, often leading to the wrong treatment being given to the patient. For the past 80 years, the only available drug for this distressing disease has been the pentavalent antimonials, which have been recently, linked to cardiac and renal toxicity. It is for this reason that Leon and co-workers, conducted a screen of traditional remedies from the Amazon rainforest to find new antileishmanial compounds. Interestingly, (-)-centrolobine 19 had already been shown to be one of the active ingredients in a herbal tea made from the wood of Centrolobum robustum that is used by the native peoples of the Amazon as a tonic cure for a variety of ailments.
(-)-Centrolobine 19 was synthesized from 20 as a starting material. Aromatic alcohol of its 20 was protected as benzyl ether 21 by benzyl bromide (K2CO3, acetone, reflux, 10 h) in quantitative yield, and this was oxidized to aldehyde 22 under Swern oxidation conditions. This aldehyde 22 on allylation using allyl bromide and zinc in THF afforded the homoallylic alcohol 23 (Barbier allylation conditions).
This homoallylic alcohol 23 upon lipase resolution gave the (R)-acetate (R)-25a and (S)-alcohol (S)-23a, and these compounds were separated by column chromatography. Enantiomeric excess has been calculated by HPLC on AS-H chiral daicel column. The effect of different solvents was also studied.
After separating (R)-25a and (S)-23a by column chromatography the alcohol (S)-23a was subject to the Mitsunobu reaction4 followed by hydrolysis gave alcohol (R)-23b and the acetate (R)-25a was hydrolysed using potassium carbonate in methanol gave the alcohol (R)-23b. This upon esterificaton using acryloyl chloride and after the ring closing metathesis using Grubbs’ 2nd generation catalyst gave unsaturated lactone (R)-27. This, upon treatment with hydrogen in the presence of Pd/C in ethyl acetate gave (R)-28 via debenzylation and hydrogenation of the double bond in one pot. This lactone (R)-28 upon treatment with p-MeO-C6H4-MgBr gave lactol, which was further treated with BF3.Et2O and Et3SiH to afford the required product 19 (Scheme 3). Its 1H, 13C NMR spectra as well as its optical rotation closely match with the previously reported data for the natural product 19.
Section B: Chemoenzymatic synthesis of (R) and (S) enantiomers of timolol


Timolol is a non-selective -blocking drug used for the topical treatment of open-angle glaucoma, an eye disease characterized by increased intraocular pressure, which results in defects in the field of vision. Like that of most of the family of aryloxypropanolamines, the -blocker activity of 29 is almost entirely due to the S enantiomer, eudismic ratio ER = 50 to 90. Nevertheless, the weakly active isomer (R)-29 maintaines a beneficial effect of bronchial constriction caused by non-selective action of (S)-29 on 1-2 receptors, and has therefore been proposed as an alternative for the treatment of glaucoma.
Optically pure timolol was prepared from 31 as a material, which was prepared from compound 30 in two steps. Compound 31 was then treated with dichloroacetone in dry DMF gave 32, which was reduced to 33 using NaBH4 in methanol almost quantitative yields. The reacemic halo hydrin 33 was then subjected to lipase-catalysed resolution. The resolution was carried out using in different lipases.
After enzymatic resolution, alcohol and acetate were isolated by column chromatography. Compounds (R)-33 and (S)-33 were converted into epoxide, which was then treated with tbutyl amine gave (S)-timolol-29 (R)-timolol-29. 


Chapter IV
 This chapter has been divided into three sections. Section-A describes the chemoenzymatic synthesis of enantiomerically enriched kavalactones, section-B describes the enantioselective total synthesis of both the stereoisomers of dihydrokawain-5-ol and section-C describes the Cu(BF4)2.xH2O catalyzed one-pot synthesis of multi component reactions (Biginelli and Strecker) under solvent-free conditions.
Section-A: Chemoenzymatic synthesis of enantiomerically enriched kawalactones
Kawalactones are a class of -pyrones and 5,6-dihydropyrones isolated from the kava plant Piper methysticum (Piperaceae), which grows widely in the South Pacific islands including Fiji and Hawaii. The extracts of its root and stem are used as a folk medicine or as a ceremonial drink in this region. Various structurally related analogues possess significant biological activities such as anticonvulsive, muscle-relaxing, sedative, analgesic, and antithrombotic, and have attracted attention in both the pharmaceutical and chemical research sectors. 
Figure 1


Enantiopure dihydrokawain 36a and 36b have been synthesized by employing β-keto ester 39 as the starting material. β-Keto ester 39 has previously been prepared by the alkylation of the dianion of methylacetoacetate 38 with benzyl bromide 37. Reduction to β-hydroxy ester 40 was achieved using sodium borohydride in methanol. The racemic β-hydroxy ester 40 was resolved enzymatically using different lipases. After separation, alcohol (R)-40 was treated with lithium diisopropyl amide (LDA) and following addition of t-butyl acetate gave hydroxy -keto ester (R)-42. The compound (R)-42 was lactonised with TFA to give (R)-43, which upon treatment with dimethyl sulphate in acetone in the presence of potassium carbonate to afford (R)-dihydrokawain (R)-36a. (S)-Dihydrokawain (R)-36b was obtained using the same procedure after hydrolysis of the acetate (S)-41 using potassium carbonate in methanol (Scheme 5).

Reagents and conditions: i. NaH, n-BuLi, THF, -50 to 0 °C, 85%; ii. NaBH4, MeOH, 0 °C to rt, 80%; iii. Lipase PS-C, vinyl acetate, diisopropyl ether; iv. K2CO3, MeOH, 90%; v. MeCO2tBu, LDA, THF, -78 °C, 85%; vi. TFA, CH2Cl2, 10 h; vii. K2CO3, acetone, (MeO)2SO2, 76% for two steps.
Racemic 46 was obtained as a pale yellow liquid by reaction of cinnamaldehyde 44 with the dianion of ethylacetoacetate 45. Racemic hydroxyl of 46 was resolved using lipases PS-C, PS-D and different acylating agents. Optically pure (R)-46 was applied for the synthesis of (R)-1 (Scheme 6).
Scheme 6

Reagents and conditions: i. NaH, n-BuLi, THF, 0 °C, 80%; ii. lipase, vinyl chloroacetate, diisopropyl ether, 20 h; iii. aq. NH3 (25%), MeOH, 0.5-1 h; iv. (a) K2CO3, MeOH, rt, 3 h; (b) acetone, (MeO)2SO2, rt, 10 h, 80% for two steps.
Section-B: Enantioselective total synthesis of both the stereoisomers of dihydrokawain-5-ol

We commenced our target molecule dihydrokawain-5-ol 36e from commercially available hydrocinnamaldehyde 47 as a starting material, which upon Wittig homologation gave unsaturated ester 49. The ester 49 was reduced to allylic alcohol 50 using DIBAL-H in CH2Cl2 in quantitative yield. Compound 50 upon Sharpless asymmetric dihydroxylation using AD-mix  at 0 °C furnished triol 51a in 90% yield. Selective 1,3 protection of 51a into six membered as p-methoxy benzylidene acetal 52 using PMB acetal, CSA in CH2Cl2 (85%), along with 1,2 protection of the five membered PMB acetal 54 in 10%. These two compounds 52 and 54 were separated by column chromatography.
Scheme 7

Reagents and conditions: i. Ph3PCHCO2Et, benzene, 6 h, reflux, 95%; ii. DIBAL-H, -78 °C, 2 h, 93%; iii. AD-mix-, t-BuOH-H2O, MeSONH2, 20 h, 0 °C, 90%; iv. PMB(OMe)2, CH2Cl2, CSA, 0 °C to rt, 1 h, 85%; v. BnBr, NaH, THF, 0 °C to rt, 4 h, 88%; vi. DIBAL-H, CH2Cl2 0 °C, 1 h, 88%; vii. Dess-Martin periodinate, CH2Cl2, 0 °C to rt, 1 h; viii. N2CHCO2Et, anhydrous SnCl2, CH2Cl2, 0 °C to rt, 85%; ix. ZrCl4, CH3CN, 0 °C to rt, 2 h, 85%; x. K2CO3, MeOH, 0 °C to rt, 2 h, then acetone, Me2SO4, 10 h, 75%; xi. TiCl4, CH2Cl2, 0 °C to rt, 15 min, 90%.
Scheme 8

i. AD-mix-, t-BuOH-H2O, MeSONH2, 20 h, 0 °C, 90%.

The hydroxyl group of 52 was protected as benzyl ether 53 (BnBr, NaH, THF) in quantitative yield. Compound 53 upon regioselective reduction with DIBAL-H gave alcohol 55. Compound 55 upon oxidation using Dess-Martin periodinane in CH2Cl2 gave aldehyde 56 in good yields. The aldehyde 56 without further purification was treated with N2CHCO2Et in the presence of anhydrous SnCl4 in CH2Cl2 gave -keto ester 57. The compound 57 upon deprotection of PMB group using ZrCl4 in acetonitrile at 0 °C gave -hydroxy--ketoester 58. This upon lactonization and methylation gave benzyl ether of dihydrokawain-5-ol 59, which upon debenzylation using TiCl4 in CH2Cl2 gave dihydrokawain-5-ol 36e. Another isomer of dihydrokawain-5-ol 36d was obtained from 50 using AD-mix .
Section-C: Cu(BF4)2·xH2O catalyzed one-pot synthesis of Biginelli and strecker reaction
Copper(II)tetrafluoroborate hydrate Cu(BF4)2·xH2O is a corrosive, moisture-sensitive, blue crystalline solid readily soluble in water and sparingly soluble in alcohols. Cu(BF4)2·xH2O is readily available and it does not require special storage conditions and is safe and stable under normal environmental conditions, Cu(BF4)2·xH2O has emerged as one of most useful reagent in various transformations such as acylation reactions and 1,1-diacetate formations. In all the cases, this reagent has been found to be superior to other available Lewis acids such as triflates, tetrafluoroborates and perchlorates with regard to short reaction times, requirement of stoichiometric amount of reagent, mild reactions conditions, solvent-free conditions and low cost. Using this catalyst we have developed novel synthetic methodologies (Biginelli and Strecekr) in one-pot, under solvent-free conditions.







(i)	Copper (II) tetrafluoroborate as a mild and efficient catalyst for the one-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones under solvent–free conditions
Scheme 9

(ii)	Copper(II)tetrafluoroborate as an efficient catalyst for the one-pot synthesis of -amino nitriles
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